• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System.美国 75 岁及以上男性中前列腺特异性抗原检测的使用情况:2006 年行为风险因素监测系统。
Prev Chronic Dis. 2010 Jul;7(4):A84. Epub 2010 Jun 15.
2
Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis.三个州的前列腺癌筛查决策:2013年行为危险因素监测系统分析
Cancer Causes Control. 2017 Mar;28(3):235-240. doi: 10.1007/s10552-017-0860-8. Epub 2017 Feb 16.
3
Prostate cancer screening practices in a large, integrated health system: 2007-2014.大型综合医疗系统中的前列腺癌筛查实践:2007 - 2014年
BJU Int. 2017 Aug;120(2):257-264. doi: 10.1111/bju.13793. Epub 2017 Feb 26.
4
Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?在美国对男性进行前列腺癌和结直肠癌筛查:实际做法是否符合证据?
JAMA. 2003 Mar 19;289(11):1414-20. doi: 10.1001/jama.289.11.1414.
5
Multilevel Small Area Estimation of Prostate-Specific Antigen Screening Test in the United States by Age Group: 2018 Behavioral Risk Factor Surveillance System.多水平小区域估计美国按年龄组划分的前列腺特异性抗原筛查检测:2018 年行为风险因素监测系统。
J Am Board Fam Med. 2021 May-Jun;34(3):634-647. doi: 10.3122/jabfm.2021.03.200505.
6
Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study.使用100%的美国德克萨斯州医疗保险公共保险索赔数据,对前列腺特异性抗原筛查率高或低的初级保健提供者所护理的老年男性进行下游检测、治疗和年度直接支付情况:一项回顾性队列研究。
BMC Health Serv Res. 2016 Jan 15;16:17. doi: 10.1186/s12913-016-1265-1.
7
Predictors of prostate cancer screening using Andersen's Behavioral Model of Health Services Use.使用安德森卫生服务利用行为模型预测前列腺癌筛查情况。
Urol Oncol. 2016 Dec;34(12):529.e9-529.e14. doi: 10.1016/j.urolonc.2016.06.016. Epub 2016 Jul 21.
8
Lifetime and recent prostate specific antigen (PSA) screening of men for prostate cancer in Canada.加拿大男性前列腺癌的终生及近期前列腺特异性抗原(PSA)筛查情况。
Can J Public Health. 2006 May-Jun;97(3):171-6. doi: 10.1007/BF03405578.
9
Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.前列腺癌筛查的预筛查讨论及前列腺特异性抗原检测
Am J Prev Med. 2015 Aug;49(2):259-63. doi: 10.1016/j.amepre.2015.02.007. Epub 2015 May 18.
10
Prostate-specific antigen testing in older men in the USA: data from the behavioral risk factor surveillance system.美国老年男性前列腺特异性抗原检测:来自行为危险因素监测系统的数据。
BJU Int. 2012 Nov;110(10):1485-90. doi: 10.1111/j.1464-410X.2012.11013.x. Epub 2012 Mar 27.

引用本文的文献

1
Prostate-Specific Antigen Screening According to Health Professional Counseling and Age in the United States.美国基于健康专业人士咨询和年龄的前列腺特异性抗原筛查
Prostate Cancer. 2022 Jan 6;2022:8646314. doi: 10.1155/2022/8646314. eCollection 2022.
2
Use of the prostate-specific antigen (PSA) test in the United States for men age ≥65, 1999-2015: Implications for practice interventions.美国 65 岁及以上男性中前列腺特异性抗原(PSA)检测的使用:对实践干预的影响。
Cancer Rep (Hoboken). 2021 Aug;4(4):e1352. doi: 10.1002/cnr2.1352. Epub 2021 May 1.
3
Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study.与澳大利亚男性进行前列腺特异性抗原检测相关的因素:新南威尔士州 45 岁及以上人群研究分析。
Sci Rep. 2018 Mar 9;8(1):4261. doi: 10.1038/s41598-018-22589-y.
4
Persuasive Interventions for Controversial Cancer Screening Recommendations: Testing a Novel Approach to Help Patients Make Evidence-Based Decisions.针对有争议的癌症筛查建议的劝导性干预措施:测试一种帮助患者做出基于证据的决策的新方法。
Ann Fam Med. 2017 Jan;15(1):48-55. doi: 10.1370/afm.1996. Epub 2017 Jan 6.
5
Shared decision making in prostate-specific antigen testing with men older than 70 years.70 岁以上男性前列腺特异性抗原检测的共同决策。
J Am Board Fam Med. 2013 Jul-Aug;26(4):401-8. doi: 10.3122/jabfm.2013.04.120267.
6
Older Korean American men's prostate cancer screening behavior: the prime role of culture.老年韩裔美国男性的前列腺癌筛查行为:文化的主要作用。
J Immigr Minor Health. 2013 Dec;15(6):1030-7. doi: 10.1007/s10903-013-9804-x.
7
Remaining Life Expectancy Measurement and PSA Screening of Older Men.老年男性剩余预期寿命的测量与前列腺特异性抗原筛查
J Geriatr Oncol. 2012 Jul 1;3(3):196-204. doi: 10.1016/j.jgo.2012.02.003.
8
Medical center characteristics associated with PSA screening in elderly veterans with limited life expectancy.与预期寿命有限的老年退伍军人中 PSA 筛查相关的医疗中心特征。
J Gen Intern Med. 2012 Jun;27(6):653-60. doi: 10.1007/s11606-011-1945-9. Epub 2011 Dec 17.

本文引用的文献

1
Prostate-specific antigen testing among the elderly in community-based family medicine practices.社区家庭医疗实践中老年人的前列腺特异性抗原检测
J Am Board Fam Med. 2009 May-Jun;22(3):257-65. doi: 10.3122/jabfm.2009.03.080136.
2
The relative contributions of race/ethnicity, socioeconomic status, health, and social relationships to life satisfaction in the United States.种族/族裔、社会经济地位、健康状况和社会关系对美国生活满意度的相对贡献。
Qual Life Res. 2009 Mar;18(2):179-89. doi: 10.1007/s11136-008-9426-2. Epub 2008 Dec 12.
3
Prostate-specific antigen screening among young men in the United States.美国年轻男性的前列腺特异性抗原筛查。
Cancer. 2008 Sep 15;113(6):1315-23. doi: 10.1002/cncr.23667.
4
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.前列腺癌筛查:美国预防服务工作组建议声明
Ann Intern Med. 2008 Aug 5;149(3):185-91. doi: 10.7326/0003-4819-149-3-200808050-00008.
5
Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.系统评价:临床局限性前列腺癌治疗方法的比较效果与危害
Ann Intern Med. 2008 Mar 18;148(6):435-48. doi: 10.7326/0003-4819-148-6-200803180-00209. Epub 2008 Feb 4.
6
Cost analysis of screening for, diagnosing, and staging prostate cancer based on a systematic review of published studies.基于对已发表研究的系统评价对前列腺癌筛查、诊断及分期的成本分析
Prev Chronic Dis. 2007 Oct;4(4):A100. Epub 2007 Sep 15.
7
Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects.2007年美国的癌症筛查:当前指南、实践与前景综述
CA Cancer J Clin. 2007 Mar-Apr;57(2):90-104. doi: 10.3322/canjclin.57.2.90.
8
PSA testing: public policy or private penchant?前列腺特异性抗原检测:公共政策还是个人偏好?
JAMA. 2006 Nov 15;296(19):2371-3. doi: 10.1001/jama.296.19.2371.
9
PSA screening among elderly men with limited life expectancies.预期寿命有限的老年男性的前列腺特异性抗原(PSA)筛查。
JAMA. 2006 Nov 15;296(19):2336-42. doi: 10.1001/jama.296.19.2336.
10
Prostate specific antigen testing in men older than 75 years in the United States.美国75岁以上男性的前列腺特异性抗原检测
J Urol. 2006 Aug;176(2):511-4. doi: 10.1016/j.juro.2006.03.060.

美国 75 岁及以上男性中前列腺特异性抗原检测的使用情况:2006 年行为风险因素监测系统。

Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System.

机构信息

Centers for Disease Control and Prevention, 4770 Buford Hwy, Mailstop K-55, Atlanta, GA 30341, USA.

出版信息

Prev Chronic Dis. 2010 Jul;7(4):A84. Epub 2010 Jun 15.

PMID:20550842
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2901582/
Abstract

INTRODUCTION

In 2008, the US Preventive Services Task Force (USPSTF) updated prostate cancer screening guidelines to recommend against screening for prostate cancer in men aged 75 years or older. We describe the prevalence of prostate-specific antigen (PSA) testing in this population and identify factors that may be correlated with the use of this test.

METHODS

Data came from the 2006 Behavioral Risk Factor Surveillance System. We assessed the status of PSA testing in the past year among 9,033 US men aged 76 or older who had no history of prostate cancer. We conducted descriptive and multiple logistic regression analyses to assess associations of PSA testing with certain sociodemographic and psychosocial factors.

RESULTS

Overall, 60% of men aged 76 or older reported having a PSA test in the past year. Men who had health insurance, were satisfied with life, or always had emotional support were significantly more likely to report having a PSA test in the past year. However, men who had no routine health checkup; were divorced, widowed, or separated; or had less than a high school education were significantly less likely to report having had a PSA test.

CONCLUSION

PSA testing is common among men aged 75 or older in the United States. Certain sociodemographic and psychosocial factors were associated with receipt of this test. This study may not only provide baseline data to evaluate acceptance and implementation of the USPSTF screening guidelines but may also help physicians and public health providers better understand these sociodemographic and psychosocial factors in this population.

摘要

简介

2008 年,美国预防服务工作组(USPSTF)更新了前列腺癌筛查指南,建议 75 岁及以上男性不要进行前列腺癌筛查。我们描述了该人群中前列腺特异性抗原(PSA)检测的流行情况,并确定了可能与该检测使用相关的因素。

方法

数据来自 2006 年行为危险因素监测系统。我们评估了 9033 名年龄在 76 岁及以上、无前列腺癌病史的美国男性在过去一年中 PSA 检测的状况。我们进行了描述性和多逻辑回归分析,以评估 PSA 检测与某些社会人口学和心理社会因素的相关性。

结果

总体而言,60%的 76 岁及以上男性报告在过去一年中进行了 PSA 检测。有医疗保险、对生活满意或始终得到情感支持的男性更有可能在过去一年中进行 PSA 检测。然而,没有常规健康检查、离婚、丧偶或分居、或受教育程度低于高中的男性进行 PSA 检测的可能性显著降低。

结论

在美国,75 岁或以上男性中 PSA 检测很常见。某些社会人口学和心理社会因素与接受这项检测有关。这项研究不仅可以提供基线数据来评估 USPSTF 筛查指南的接受和实施情况,还可以帮助医生和公共卫生提供者更好地了解该人群中的这些社会人口学和心理社会因素。